Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Asnis

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biological Psychiatry|September 1, 1988
Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjectsS W Carson, U Halbreich, C M Yeh, et al.
Biological Psychiatry|July 15, 1992
Serotonin receptor sensitivity and suicideM L Korn, G Asnis, S L Brown, et al.
BMC Health Services Research|October 26, 2024
Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patientsJeffrey Thomas Yorio, Aviva G Asnis-Alibozek, Vijay Kasturi, et al.
Psychiatry Research|January 1, 1987
Diurnal rhythm of plasma MHPG in endogenous depressionU Halbreich, S Goldstein, N Sharpless, et al.
Psychopharmacology Bulletin|January 1, 1984
Sex differences in response to psychopharmacological interventions in humansU Halbreich, G Asnis, S Goldstein, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1980
Neuroendocrine studies of major depressive disorderE J Sachar, R S Nathan, G Asnis, et al.
Archives of General Psychiatry|July 1, 1980
Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressedE J Sachar, G Asnis, R S Nathan, et al.
Psychiatry Research|July 1, 1984
A comparative study of the pituitary TSH response to thyrotropin in outpatient depressivesP J McGrath, F M Quitkin, J W Stewart, et al.
Biological Psychiatry|December 1, 1986
Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisolU Halbreich, S Naor, G Asnis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifenEdgardo Rivera, Vicente Valero, Deborah Francis, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biological Psychiatry|September 1, 1988
Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjectsS W Carson, U Halbreich, C M Yeh, et al.
Biological Psychiatry|July 15, 1992
Serotonin receptor sensitivity and suicideM L Korn, G Asnis, S L Brown, et al.
BMC Health Services Research|October 26, 2024
Estimated cost of VEGFR TKI associated adverse events in metastatic renal cell carcinoma patientsJeffrey Thomas Yorio, Aviva G Asnis-Alibozek, Vijay Kasturi, et al.
Psychiatry Research|January 1, 1987
Diurnal rhythm of plasma MHPG in endogenous depressionU Halbreich, S Goldstein, N Sharpless, et al.
Psychopharmacology Bulletin|January 1, 1984
Sex differences in response to psychopharmacological interventions in humansU Halbreich, G Asnis, S Goldstein, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1980
Neuroendocrine studies of major depressive disorderE J Sachar, R S Nathan, G Asnis, et al.
Archives of General Psychiatry|July 1, 1980
Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressedE J Sachar, G Asnis, R S Nathan, et al.
Psychiatry Research|July 1, 1984
A comparative study of the pituitary TSH response to thyrotropin in outpatient depressivesP J McGrath, F M Quitkin, J W Stewart, et al.
Biological Psychiatry|December 1, 1986
Decreased dexamethasone suppression in endogenously depressed patients with normal basal plasma levels of cortisolU Halbreich, S Naor, G Asnis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifenEdgardo Rivera, Vicente Valero, Deborah Francis, et al.
Pageof 3